The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Harm reduction for the 15.6 million people who inject drugs remains a critical cornerstone to respond to the global epidemics of HIV and hepatitis C – but progress has stagnated.
Landmark research from Indonesia reveals a missed opportunity to immediately link key affected populations living with HIV to treatment services.
With a 174% rise in new HIV infections from 2010 to 2017 – condom promotion is the first piece of the prevention puzzle for the Philippines.
On International Youth Day (12 August), we look at the importance of youth involvement and safe spaces to respond to the HIV challenge related to the youth bulge.
New study maps HIV risk factors among men who have sex with men in Thailand, showing internet ‘hook-ups’, methamphetamine use and chemsex to be the new big drivers of HIV.
Burundi learn about harm reduction from one of the pioneers on the African continent.
A new study among people entering prison in the USA suggests ‘opt-out’ testing approaches for HIV and hepatitis C virus (HCV) may need reconsideration.
Long-term survivors – those diagnosed before effective treatment for HIV was around – face unique challenges relating to their mental and physical health.
Juno Roche – writer, campaigner and woman living with HIV – shares her experiences on risk, HIV and being trans for International Transgender Day of Visibility (31 March).
PrEP, undetectable, on treatment … what does it all mean? Here we give you a quick run through in our jargon-busting blog.
